Simplex Trading
IMVT icon

Simplex Trading’s Immunovant IMVT Stock Holding History

Simplex Trading’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$363K Sell
14,600
-4,200
-22% -$109K ﹤0.01% 3622
2025
Q4 		$478K Buy
18,800
+3,800
+25% +$84.7K ﹤0.01% 3349
2025
Q3 		$241K Sell
15,000
-13,900
-48% -$225K ﹤0.01% 4715
2025
Q2 		$462K Sell
28,900
-75,500
-72% -$1.14M ﹤0.01% 3583
2025
Q1 		$1.78M Sell
104,400
-28,100
-21% -$588K ﹤0.01% 2147
2024
Q4 		$3.28M Buy
132,500
+90,000
+212% +$2.55M ﹤0.01% 1785
2024
Q3 		$1.21M Buy
42,500
+2,900
+7% +$85.5K ﹤0.01% 2748
2024
Q2 		$1.04M Buy
39,600
+13,600
+52% +$387K ﹤0.01% 2868
2024
Q1 		$840K Sell
26,000
-2,000
-7% -$73K ﹤0.01% 3300
2023
Q4 		$1.18M Sell
28,000
-37,200
-57% -$1.37M ﹤0.01% 2854
2023
Q3 		$2.5M Buy
65,200
+59,000
+952% +$1.33M ﹤0.01% 1898
2023
Q2 		$117K Sell
6,200
-3,900
-39% -$72.7K ﹤0.01% 4879
2023
Q1 		$156K Buy
10,100
+5,500
+120% +$95.4K ﹤0.01% 4614
2022
Q4 		$81K Buy
4,600
+4,000
+667% +$50.4K ﹤0.01% 5324
2022
Q3 		$3K Sell
600
-6,300
-91% -$30.8K ﹤0.01% 9097
2022
Q2 		$26K Sell
6,900
-1,400
-17% -$6.05K ﹤0.01% 7296
2022
Q1 		$45K Sell
8,300
-57,200
-87% -$356K ﹤0.01% 7276
2021
Q4 		$558K Sell
65,500
-359,700
-85% -$2.97M ﹤0.01% 3646
2021
Q3 		$4.83M Sell
425,200
-9,200
-2% -$83K ﹤0.01% 1239
2021
Q2 		$4.59M Buy
434,400
+434,365
+1,241,043% +$6.06M ﹤0.01% 1262
2021
Q1 		$56K Buy
+35
New +$923 ﹤0.01% 6462

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Simplex Trading's IMVT Position: Q1 2026 in Review

Simplex Trading increased its Immunovant (IMVT) stake by 3.9% in Q1 2026, buying an estimated $48.3K and bringing the position to 50,276 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

Simplex Trading first reported a position in IMVT in Q2 2021 and has held it in 18 quarters since. The position peaked at $4.81M in Q3 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Simplex Trading held 50,276 shares of Immunovant worth $1.25M as of Q1 2026.
  • Simplex Trading bought 1,865 Immunovant shares in Q1 2026, an estimated $48.3K.
  • Immunovant made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2270 holding.
  • Simplex Trading first reported a position in Immunovant in Q2 2021 and has held it in 18 quarters since.
  • Simplex Trading's Immunovant position peaked at $4.81M in Q3 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.